Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients with von Willebrand disease type 1, 2 and 3 - Michiels,J.J.; van Vliet,H.H.; Berneman,Z. (Clin Appl Thromb Hemost, 2007)